Literature DB >> 15947790

Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors.

M Montanari1, C Gemelli, E Tenedini, T Zanocco Marani, T Vignudelli, M Siena, R Zini, S Salati, G Chiossi, E Tagliafico, R Manfredini, A Grande, S Ferrari.   

Abstract

In spite of their apparently restricted differentiation potentiality, hematopoietic precursors are plastic cells able to trans-differentiate from a maturation lineage to another. To better characterize this differentiation plasticity, we purified CD14- and CD14+ myeloid precursors generated by 'in vitro' culture of human CD34+ hematopoietic progenitors. Morphological analysis of the investigated cell populations indicated that, as expected, they consisted of granulocyte and monocyte precursors, respectively. Treatment with differentiation inducers revealed that CD14- cells were bipotent granulo-monocyte precursors, while CD14+ cells appeared univocally committed to a terminal macrophage maturation. Flow cytometry analysis demonstrated that the conversion of granulocyte precursors to the mono-macrophage maturation lineage occurs through a differentiation transition in which the granulocyte-related myeloperoxidase enzyme and the monocyte-specific CD14 antigen are co-expressed. Expression profiling evidenced that the observed trans-differentiation process was accompanied by a remarkable upregulation of the monocyte-related MafB transcription factor.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947790     DOI: 10.1038/sj.cdd.4401679

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  8 in total

1.  The plasticity and potential of leukemia cell lines to differentiate into dendritic cells.

Authors:  Qingwei Guo; Leling Zhang; Fu Li; Guosheng Jiang
Journal:  Oncol Lett       Date:  2012-07-25       Impact factor: 2.967

2.  ZFP36L1 negatively regulates erythroid differentiation of CD34+ hematopoietic stem cells by interfering with the Stat5b pathway.

Authors:  Tatiana Vignudelli; Tommaso Selmi; Andrea Martello; Sandra Parenti; Alexis Grande; Claudia Gemelli; Tommaso Zanocco-Marani; Sergio Ferrari
Journal:  Mol Biol Cell       Date:  2010-08-11       Impact factor: 4.138

3.  Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment.

Authors:  E Tenedini; E Roncaglia; F Ferrari; C Orlandi; E Bianchi; S Bicciato; E Tagliafico; S Ferrari
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

4.  Transcription Factor MafB Suppresses Type I Interferon Production by CD14+ Monocytes in Patients With Chronic Hepatitis C.

Authors:  Tie-Mei Liu; Han Wang; Dong-Na Zhang; Guang-Ze Zhu
Journal:  Front Microbiol       Date:  2019-08-07       Impact factor: 5.640

Review 5.  From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights.

Authors:  Alexandre Anesi; Luigi Generali; Laura Sandoni; Samantha Pozzi; Alexis Grande
Journal:  Int J Mol Sci       Date:  2019-10-04       Impact factor: 5.923

6.  Genomic expression during human myelopoiesis.

Authors:  Francesco Ferrari; Stefania Bortoluzzi; Alessandro Coppe; Dario Basso; Silvio Bicciato; Roberta Zini; Claudia Gemelli; Gian Antonio Danieli; Sergio Ferrari
Journal:  BMC Genomics       Date:  2007-08-03       Impact factor: 3.969

7.  Remodeling of nuclear landscapes during human myelopoietic cell differentiation maintains co-aligned active and inactive nuclear compartments.

Authors:  Barbara Hübner; Mariana Lomiento; Fabiana Mammoli; Doris Illner; Yolanda Markaki; Sergio Ferrari; Marion Cremer; Thomas Cremer
Journal:  Epigenetics Chromatin       Date:  2015-11-17       Impact factor: 4.954

8.  Chromosome positioning in interphase nuclei of hematopoietic stem cell and myeloid precursor.

Authors:  Mariana Lomiento; Fabiana Mammoli; Emilia Maria Cristina Mazza; Silvio Bicciato; Sergio Ferrari
Journal:  Hematol Rep       Date:  2018-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.